ASX · CTQ.AX
Careteq Limited
A$0.01A$0.00 (0.0%)
Careteq Limited’s quoted price sits in the lower half of its reported 52-week range, 45.0% below the high.
Loading market information…
ASX · ANR.AX · AUD
Stock price, earnings
Quote as of Oct 29, 2026, 05:10 AM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
Anatara Lifesciences Ltd’s quoted price sits in the lower half of its reported 52-week range, 52.94% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Anatara Lifesciences Ltd’s next earnings report is currently expected on Feb 24, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Anatara Lifesciences Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Anatara Lifesciences Ltd is an Australian enterprise focused on researching, developing, and commercializing scientifically-validated therapies for digestive system ailments affecting both humans and animals. Its product portfolio includes Gastrointestinal ReProgramming (GRP), a proprietary blend combining bromelain with other evidence-based ingredients, specifically formulated to target the underlying issues of human gastrointestinal conditions such as irritable bowel syndrome and inflammatory bowel disease. The firm also offers 3FDC, designed to address anxiety, stress, or depression. In the animal health sector, Anatara provides Detach for treating diarrhea in piglets, BONIFF as an enhanced dry feed formulation for weaned piglets, and ANR-pf, a unique additive for poultry drinking water. This company was founded in 2010 and is headquartered in Carlton, Australia.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$0.01A$0.00 (0.0%)
Careteq Limited’s quoted price sits in the lower half of its reported 52-week range, 45.0% below the high.
A$0.01A$0.00 (0.0%)
Acrux Limited’s quoted price sits in the lower half of its reported 52-week range, 52.38% below the high.
$0.21$0.00 (0.0%)
Zelira Therapeutics Limited’s quoted price sits in the lower half of its reported 52-week range, 50.78% below the high.
A$0.08A$0.00 (0.0%)
TALi Digital Limited’s quoted price sits in the lower half of its reported 52-week range, 44.44% below the high.
A$0.00A$0.00 (0.0%)
Biotron Limited’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
A$0.01A$0.00 (0.0%)
Elixinol Wellness Limited’s quoted price sits in the lower half of its reported 52-week range, 72.73% below the high.
A$0.01A$0.00 (0.0%)
Imagion Biosystems Limited’s quoted price sits in the lower half of its reported 52-week range, 85.71% below the high.
A$0.08A$0.00 (0.0%)
Oakridge International Limited’s quoted price sits in the lower half of its reported 52-week range, 44.83% below the high.
